Takenaka K - Search Results

1

Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade.

Matsuda S, Kosako H, Takenaka K, Moriyama K, Sakai H, Akiyama T, Gotoh Y, Nishida E. Matsuda S, et al. Among authors: takenaka k. EMBO J. 1992 Mar;11(3):973-82. doi: 10.1002/j.1460-2075.1992.tb05136.x. EMBO J. 1992. PMID: 1312468 Free PMC article.

2

Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites.

Gotoh Y, Matsuda S, Takenaka K, Hattori S, Iwamatsu A, Ishikawa M, Kosako H, Nishida E. Gotoh Y, et al. Among authors: takenaka k. Oncogene. 1994 Jul;9(7):1891-8. Oncogene. 1994. PMID: 8208535

3

[Functions of MAP kinase in cell cycle regulation].

Takenaka K, Gotoh Y, Nishida E. Takenaka K, et al. Tanpakushitsu Kakusan Koso. 1996 Sep;41(12 Suppl):1658-65. Tanpakushitsu Kakusan Koso. 1996. PMID: 8890620 Review. Japanese. No abstract available.

4

MAP kinase is required for the spindle assembly checkpoint but is dispensable for the normal M phase entry and exit in Xenopus egg cell cycle extracts.

Takenaka K, Gotoh Y, Nishida E. Takenaka K, et al. J Cell Biol. 1997 Mar 10;136(5):1091-7. doi: 10.1083/jcb.136.5.1091. J Cell Biol. 1997. PMID: 9060473 Free PMC article.

5

Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest.

Takenaka K, Moriguchi T, Nishida E. Takenaka K, et al. Science. 1998 Apr 24;280(5363):599-602. doi: 10.1126/science.280.5363.599. Science. 1998. PMID: 9554853

6

MEK and Cdc2 kinase are sequentially required for Golgi disassembly in MDCK cells by the mitotic Xenopus extracts.

Kano F, Takenaka K, Yamamoto A, Nagayama K, Nishida E, Murata M. Kano F, et al. Among authors: takenaka k. J Cell Biol. 2000 Apr 17;149(2):357-68. doi: 10.1083/jcb.149.2.357. J Cell Biol. 2000. PMID: 10769028 Free PMC article.

7

FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.

Iejima D, Minegishi Y, Takenaka K, Siswanto A, Watanabe M, Huang L, Watanabe T, Tanaka F, Kuroda M, Gotoh N. Iejima D, et al. Among authors: takenaka k. Oncogene. 2010 May 27;29(21):3087-99. doi: 10.1038/onc.2010.69. Epub 2010 Mar 15. Oncogene. 2010. PMID: 20228838

8

Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.

Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H, Tanaka F. Chen F, et al. Among authors: takenaka k. Clin Cancer Res. 2004 Dec 15;10(24):8548-53. doi: 10.1158/1078-0432.CCR-04-0950. Clin Cancer Res. 2004. PMID: 15623638

9

The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer.

Takenaka K, Katakura H, Chen F, Ogawa E, Adachi M, Wada H, Tanaka F. Takenaka K, et al. Cancer Lett. 2007 Feb 8;246(1-2):34-40. doi: 10.1016/j.canlet.2006.01.022. Epub 2006 Mar 10. Cancer Lett. 2007. PMID: 16530326

10

Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC).

Ogawa E, Takenaka K, Katakura H, Adachi M, Otake Y, Toda Y, Kotani H, Manabe T, Wada H, Tanaka F. Ogawa E, et al. Among authors: takenaka k. Ann Surg Oncol. 2008 Feb;15(2):547-54. doi: 10.1245/s10434-007-9653-8. Epub 2007 Nov 28. Ann Surg Oncol. 2008. PMID: 18043979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,143 results

Search Page

Filters